LeadIQ logo
Learn more at LeadIQ.com

Insights

Influenza Vaccine Innovations CSL Seqirus is at the forefront of developing innovative influenza vaccines, as evidenced by recent studies showcasing the clinical and economic value of their cell-based and adjuvanted seasonal influenza vaccines. This presents a strong sales opportunity for targeting healthcare providers, pharmacies, and government agencies looking for cutting-edge vaccine solutions.

Specialized Avian Influenza Vaccines With a focus on developing human vaccines against highly pathogenic subtypes of avian influenza, CSL Seqirus is positioned uniquely in the market. Sales teams can leverage this specialization to target poultry farms, veterinary clinics, and international health organizations combating avian influenza outbreaks, presenting a lucrative niche market opportunity.

Strategic Government Partnerships Collaboration with HHS for alternative vaccine solutions underscores CSL Seqirus's commitment to public health preparedness. This partnership opens doors for sales representatives to engage with government agencies, emergency response departments, and strategic stockpilers seeking reliable and diversified vaccine supply sources.

Manufacturing Leadership Appointment The recent hire of Jonathan Kegerise as vice president of manufacturing signals CSL Seqirus's focus on production excellence. Sales professionals can capitalize on this leadership change to engage with pharmaceutical suppliers, CMOs, and manufacturing facilities seeking high-quality vaccine manufacturing partners.

Competitive Landscape Analysis Given its revenue scale and market presence, CSL Seqirus competes with industry giants like Roche, Abbott, and Johnson & Johnson. Conducting a competitive analysis can provide sales teams with insights on product differentiation, pricing strategies, and market gaps to effectively position CSL Seqirus's offerings and capture market share.

Similar companies to CSL Seqirus

CSL Seqirus Tech Stack

CSL Seqirus uses 8 technology products and services including Sitecore, core-js, Hammer.js, and more. Explore CSL Seqirus's tech stack below.

  • Sitecore
    Content Management System
  • core-js
    Javascript Libraries
  • Hammer.js
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • Babel
    Miscellaneous
  • Google Tag Manager
    Tag Management
  • Video.js
    Video Players

CSL Seqirus's Email Address Formats

CSL Seqirus uses at least 2 format(s):
CSL Seqirus Email FormatsExamplePercentage
First.Last@seqirus.comJohn.Doe@seqirus.com
92%
First.Middle@seqirus.comJohn.Michael@seqirus.com
1%
FirstLast@seqirus.comJohnDoe@seqirus.com
1%
Last.First@seqirus.comDoe.John@seqirus.com
1%
F_Last@seqirus.comJ_Doe@seqirus.com
1%
First-L@seqirus.comJohn-D@seqirus.com
1%
First_L@seqirus.comJohn_D@seqirus.com
1%
First.MiddleLast@seqirus.comJohn.MichaelDoe@seqirus.com
1%
FirstLa@seqirus.comJohnDo@seqirus.com
1%

Frequently Asked Questions

Where is CSL Seqirus's headquarters located?

Minus sign iconPlus sign icon
CSL Seqirus's main headquarters is located at 25 Deforest Ave Summit, New Jersey 07901 US. The company has employees across 6 continents, including North AmericaOceaniaEurope.

What is CSL Seqirus's official website and social media links?

Minus sign iconPlus sign icon
CSL Seqirus's official website is cslseqirus.com and has social profiles on LinkedIn.

How much revenue does CSL Seqirus generate?

Minus sign iconPlus sign icon
As of April 2023, CSL Seqirus's annual revenue reached $5B.

What is CSL Seqirus's NAICS code?

Minus sign iconPlus sign icon
CSL Seqirus's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does CSL Seqirus have currently?

Minus sign iconPlus sign icon
As of April 2023, CSL Seqirus has approximately 2.7K employees across 6 continents, including North AmericaOceaniaEurope. Key team members include Vice President Commercial Operations, North America: D. R.Vice President Commercial Development: S. M.Vice President Operations And Site Head Holly Springs: J. A.. Explore CSL Seqirus's employee directory with LeadIQ.

What industry does CSL Seqirus belong to?

Minus sign iconPlus sign icon
CSL Seqirus operates in the Pharmaceutical Manufacturing industry.

What technology does CSL Seqirus use?

Minus sign iconPlus sign icon
CSL Seqirus's tech stack includes Sitecorecore-jsHammer.jsjQueryOpen GraphBabelGoogle Tag ManagerVideo.js.

What is CSL Seqirus's email format?

Minus sign iconPlus sign icon
CSL Seqirus's email format typically follows the pattern of . Find more CSL Seqirus email formats with LeadIQ.

When was CSL Seqirus founded?

Minus sign iconPlus sign icon
CSL Seqirus was founded in 1916.
CSL Seqirus

CSL Seqirus

Pharmaceutical ManufacturingNew Jersey, United States1001-5000 Employees

CSL Seqirus, a business unit of CSL, was created from the combined strength and expertise of bioCSL and the influenza vaccines business formerly owned by Novartis. In July 2015, the two businesses joined forces to create CSL Seqirus, now the second largest influenza vaccine company in the world.  With extensive research and production expertise and manufacturing plants in the US, UK, Germany and Australia, CSL Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally. CSL Seqirus has a workforce of over 3,000 employees, significant manufacturing capacity and a commercial presence in over 20 countries. 
 
In Australia and New Zealand, CSL Seqirus markets a comprehensive range of vaccines and specialty pharmaceutical products. It also manufactures products of national significance for Australia, including antivenoms and Q fever vaccine. See our community guidelines: https://bit.ly/3QZbZeZ

Section iconCompany Overview

Headquarters
25 Deforest Ave Summit, New Jersey 07901 US
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1916
Employees
1001-5000

Section iconFunding & Financials

  • $1B

    CSL Seqirus's revenue is in the range of $1B

Section iconFunding & Financials

  • $1B

    CSL Seqirus's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.